Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1982 1
1984 1
1986 2
1987 3
1996 2
1998 1
1999 1
2000 1
2001 1
2003 2
2010 2
2011 3
2012 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Anticancer oral therapy: emerging related issues.
Banna GL, Collovà E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferraù F. Banna GL, et al. Among authors: buscarino c. Cancer Treat Rev. 2010 Dec;36(8):595-605. doi: 10.1016/j.ctrv.2010.04.005. Epub 2010 Jun 8. Cancer Treat Rev. 2010. PMID: 20570443 Review.
Genomic analysis: toward a new approach in breast cancer management.
Cavallaro S, Paratore S, de Snoo F, Salomone E, Villari L, Buscarino C, Ferraù F, Banna G, Furci M, Strazzanti A, Cunsolo R, Pezzino S, Gangi S, Basile F. Cavallaro S, et al. Among authors: buscarino c. Crit Rev Oncol Hematol. 2012 Mar;81(3):207-23. doi: 10.1016/j.critrevonc.2011.03.006. Epub 2011 Apr 20. Crit Rev Oncol Hematol. 2012. PMID: 21511492 Review.
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS. Steere AC, et al. Among authors: buscarino c. N Engl J Med. 1998 Jul 23;339(4):209-15. doi: 10.1056/NEJM199807233390401. N Engl J Med. 1998. PMID: 9673298 Free article. Clinical Trial.
Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.
Sikand VK, Halsey N, Krause PJ, Sood SK, Geller R, Van Hoecke C, Buscarino C, Parenti D; Pediatric Lyme Vaccine Study Group. Sikand VK, et al. Among authors: buscarino c. Pediatrics. 2001 Jul;108(1):123-8. doi: 10.1542/peds.108.1.123. Pediatrics. 2001. PMID: 11433064 Clinical Trial.
23 results